News | March 11, 2009

Leading Middle East Cancer Hospital Acquires Varian’s RapidArc

March 11, 2009 - One of the leading cancer centers in the Middle East has acquired two advanced radiotherapy devices from Varian Medical Systems equipped with RapidArc technology for fast and precise treatments.

Al Amal Hospital in Doha, Qatar, is replacing four-year-old linear accelerators with Trilogy and Clinac iX devices, aiming to provide patients with more modern and efficient treatments.

The new equipment, ordered in February and scheduled to be installed in May, will enable clinicians in Qatar's only radiation therapy center to begin treatments using RapidArc, Varian's latest technology for delivering image-guided intensity-modulated radiotherapy (IMRT) with greater precision and up to eight times faster than is possible with conventional IMRT.

Dr. Noora Mohammed Al-Hammadi, head of the department of radiation oncology, said, "Evidence suggests that RapidArc will revolutionize the way IMRT is delivered and potentially improve patient outcomes. Faster treatment that more closely conform radiation doses to the size, shape and location of the tumor are always desirable in radiotherapy, for both machine throughput as well as patient outcomes. We are very excited about the potential of RapidArc."

RapidArc delivers a precise and efficient treatment in single or multiple arcs of the medical linear accelerator around the patient. Varian's Clinac and Trilogy accelerators can target beams at a tumor while continuously rotating around the patient. Conventional IMRT treatments are slower for radiotherapists because they use many fixed angle beams rather than a continuous rotational beam.

For more information: www.varian.com

Related Content

Vinai Gondi, M.D., the Director of Research at the Northwestern Medicine Chicago Proton Center, Co-director of the Brain Tumor Center at Northwestern Medicine Cancer Center, Warrenville, and lead author of the NRG-BN001 abstract.

Vinai Gondi, M.D., director of research at the Northwestern Medicine Chicago Proton Center, co-director of the Brain Tumor Center at Northwestern Medicine Cancer Center, Warrenville, and lead author of the NRG-BN001 abstract.

News | Intensity Modulated Radiation Therapy (IMRT) | October 27, 2020
October 27, 2020 — A...
PTW announces first North American installation and FDA 510(k) clearance of Beamscan MR motorized 3-D water phantom

PTW Beamscan MR for Elekta Unity

News | Radiation Oncology | April 17, 2020
April 17, 2020 — PTW has installed the first Beamscan MR motor...
Elekta Unity MR Linac system
News | Radiation Oncology | January 30, 2020
January 30, 2020 — Elekta announced that it signed a contract wit
IBA ProteusOne proton therapy system
News | Proton Therapy | January 29, 2020
January 29, 2020 — IBA (Ion Beam Applications S.A.) announced that it has signed a contract and received a major down
IBA Dosimetry Releases myQA Machines Software at ASTRO 2019
Technology | Quality Assurance (QA) | September 12, 2019
IBA Dosimetry GmbH announced the launch of the new enhanced myQA Machines 2019 software environment at the upcoming...
Accuray Launches Synchrony Motion Tracking and Correction Technology for Radixact System
Technology | Image Guided Radiation Therapy (IGRT) | April 24, 2019
Accuray announced the launch of its Synchrony motion tracking and correction technology to be used with the Radixact...
Hypofractionated Radiation Provides Same Prostate Cancer Outcomes as Conventional Radiation
News | Intensity Modulated Radiation Therapy (IMRT) | October 31, 2018
An analysis led by researchers at Philadelphia’s Fox Chase Cancer Center found treating localized prostate cancer with...